SynBiotic SE
Save
32.93M
Market cap
–
Current P/E
294.12x
Forward P/E
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE.
Similar securities
Based on sector and market capitalization
Report issue